Oxford Immune Algorithmics (OIA) Successfully Completes QMS ISO 13485
Oxford Immune Algorithmics (OIA), the creators of Algocyte, is delighted to announce it has successfully received ISO 13485 certification status from NQA.
Oxford Immune Algorithmics is Part of the UAE and Hub71’s World Tour to #LondonTechWeek and #VivaTech in Paris.
This past week represented a significant one for Oxford Immune Algorithmics (OIA).
Oxford Immune Algorithmics’ (OIA) AI-driven Solution Algocyte Featured on UK’s Open Access Media Portal on SARS-CoV-2 and Long Covid
We recently published an article on the U.K.’s Open Access Media portal entitled, ‘Could Immune Monitoring Be the Route to a Long-Covid Test?‘
Oxford Immune Algorithmics, Representing the UK as One of its Most Innovative Companies, Successfully Concludes Multiple Events in Dubai
Oxford Immune Algorithmics announced they are exhibiting at MWC/4YFN in Barcelona, February 28th – March 3rd.
U.K. Biotech, Oxford Immune Algorithmics (OIA) Presents Algocyte at MWC /4YFN Barcelona in the Great Britain & Northern Ireland Pavilion
Oxford Immune Algorithmics (OIA), the award-winning A.I. company that specialises in rapid at-home testing for immune health monitoring, and creators of Algocyte the AI-driven solution that thinks like a scientist, marked a week of significant achievement in Dubai